Published in Women's Health Weekly, March 20th, 1995
Guido Cavaletti et al., from the University of Milan, Italy, remark that the recent discovery that taxol can induce tumor response in platinum-resistant cancers might provide a second line defense for patients, who up to now, have not had a satisfactory chemotherapeutic available to them ("Peripheral Neurotoxicity of Taxol in Patients Previously Treated with Cisplatin," Cancer, March 1, 1995;75(5):1141-50).
Cavaletti et al. proposed "in view of the possible wider clinical use of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly